These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 21076464)

  • 21. Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.
    Diaz LK; Cryns VL; Symmans WF; Sneige N
    Adv Anat Pathol; 2007 Nov; 14(6):419-30. PubMed ID: 18049131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
    Cheang MC; Voduc D; Bajdik C; Leung S; McKinney S; Chia SK; Perou CM; Nielsen TO
    Clin Cancer Res; 2008 Mar; 14(5):1368-76. PubMed ID: 18316557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells.
    Wang D; Huang J; Hu Z
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.011932. PubMed ID: 22086602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
    Itoh M; Iwamoto T; Matsuoka J; Nogami T; Motoki T; Shien T; Taira N; Niikura N; Hayashi N; Ohtani S; Higaki K; Fujiwara T; Doihara H; Symmans WF; Pusztai L
    Breast Cancer Res Treat; 2014 Jan; 143(2):403-9. PubMed ID: 24337596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologic profiling of lymph node negative breast cancers by means of microRNA expression.
    Janssen EA; Slewa A; Gudlaugsson E; Jonsdottir K; Skaland I; Søiland H; Baak JP
    Mod Pathol; 2010 Dec; 23(12):1567-76. PubMed ID: 20818337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metaplastic breast carcinomas are basal-like tumours.
    Reis-Filho JS; Milanezi F; Steele D; Savage K; Simpson PT; Nesland JM; Pereira EM; Lakhani SR; Schmitt FC
    Histopathology; 2006 Jul; 49(1):10-21. PubMed ID: 16842242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers.
    Bidard FC; Conforti R; Boulet T; Michiels S; Delaloge S; André F
    Ann Oncol; 2007 Jul; 18(7):1285-6. PubMed ID: 17675400
    [No Abstract]   [Full Text] [Related]  

  • 28. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
    Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
    J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.
    Moestue SA; Borgan E; Huuse EM; Lindholm EM; Sitter B; Børresen-Dale AL; Engebraaten O; Maelandsmo GM; Gribbestad IS
    BMC Cancer; 2010 Aug; 10():433. PubMed ID: 20716336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells.
    Yunokawa M; Koizumi F; Kitamura Y; Katanasaka Y; Okamoto N; Kodaira M; Yonemori K; Shimizu C; Ando M; Masutomi K; Yoshida T; Fujiwara Y; Tamura K
    Cancer Sci; 2012 Sep; 103(9):1665-71. PubMed ID: 22703543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
    Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
    Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.
    Venkitaraman R
    Expert Rev Anticancer Ther; 2010 Feb; 10(2):199-207. PubMed ID: 20131996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular stratification of triple-negative breast cancers.
    Perou CM
    Oncologist; 2011; 16 Suppl 1():61-70. PubMed ID: 21278442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
    Nielsen TO; Hsu FD; Jensen K; Cheang M; Karaca G; Hu Z; Hernandez-Boussard T; Livasy C; Cowan D; Dressler L; Akslen LA; Ragaz J; Gown AM; Gilks CB; van de Rijn M; Perou CM
    Clin Cancer Res; 2004 Aug; 10(16):5367-74. PubMed ID: 15328174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of triple-negative breast cancer.
    de Ruijter TC; Veeck J; de Hoon JP; van Engeland M; Tjan-Heijnen VC
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):183-92. PubMed ID: 21069385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies.
    Toft DJ; Cryns VL
    Mol Endocrinol; 2011 Feb; 25(2):199-211. PubMed ID: 20861225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MYC amplification in subtypes of breast cancers in African American women.
    Naab TJ; Gautam A; Ricks-Santi L; Esnakula AK; Kanaan YM; DeWitty RL; Asgedom G; Makambi KH; Abawi M; Blancato JK
    BMC Cancer; 2018 Mar; 18(1):274. PubMed ID: 29523126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.
    Yam C; Mani SA; Moulder SL
    Oncologist; 2017 Sep; 22(9):1086-1093. PubMed ID: 28559413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance.
    Mohammed RA; Ellis IO; Mahmmod AM; Hawkes EC; Green AR; Rakha EA; Martin SG
    Mod Pathol; 2011 Jun; 24(6):774-85. PubMed ID: 21378756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.